NDC 63304-926 – Guanfacine
Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · Oral
Product NDC63304-926
Product details
- Brand name
- Guanfacine
- Generic name
- Guanfacine
- Labeler
- Sun Pharmaceutical Industries, Inc
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA205689
- Marketed since
- August 17, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Active ingredients
- Guanfacine Hydrochloride 3 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 63304-926-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-01) | Aug 17, 2018 |
| 63304-926-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-05) | Aug 17, 2018 |
| 63304-926-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-926-30) | Aug 17, 2018 |
Other Guanfacine products
- 50090-7644 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7129 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 73141-018 Guanfacine Hydrochloride 1 mg/1 · Tablet · A2A Integrated Pharmaceuticals
- 73141-019 Guanfacine Hydrochloride 2 mg/1 · Tablet · A2A Integrated Pharmaceuticals
- 0228-2850 Guanfacine Hydrochloride 1 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 0228-2851 Guanfacine Hydrochloride 2 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 0228-2853 Guanfacine Hydrochloride 3 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 0228-2855 Guanfacine Hydrochloride 4 mg/1 · Tablet, Extended Release · Actavis Pharma, Inc.
- 0591-0444 Guanfacine Hydrochloride 1 mg/1 · Tablet · Actavis Pharma, Inc.
- 0591-0453 Guanfacine Hydrochloride 2 mg/1 · Tablet · Actavis Pharma, Inc.
- 72888-224 Guanfacine Hydrochloride 1 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 72888-227 Guanfacine Hydrochloride 4 mg/1 · Tablet, Extended Release · Advagen Pharma Limited